A β-Blocker Trial in Dialysis Patients: Is It Feasible and Worthwhile?

Affiliations

¹ Tufts Medical Center, Boston, Massachusetts. Electronic address: dmiskulin@tuftsmedicalcenter.org.
² Tufts Medical Center, Boston, Massachusetts.

Editorial

Dana Miskulin et al. Am J Kidney Dis. 2016 Jun.

. 2016 Jun;67(6):822-5.

doi: 10.1053/j.ajkd.2016.03.413.

¹ Tufts Medical Center, Boston, Massachusetts. Electronic address: dmiskulin@tuftsmedicalcenter.org.
² Tufts Medical Center, Boston, Massachusetts.

No abstract available

Comment on

The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial.
Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Isbel NM, Krum H, Pascoe EM, Perkovic V, Scaria A, Tonkin AM, Vergara LA, Hawley CM; BLOCADE Study Collaborative Group. Roberts MA, et al. Am J Kidney Dis. 2016 Jun;67(6):902-11. doi: 10.1053/j.ajkd.2015.10.029. Epub 2015 Dec 22. Am J Kidney Dis. 2016. PMID: 26717861 Clinical Trial.